Pfizer to co-promote Exact Sciences' Cologuard

Share this
Pfizer to co-promote Exact Sciences' Cologuard

Pfizer to co-promote Exact Sciences' Cologuard


  • Pfizer signed a Co-promotion agreement for Exact Sciences Cologuard-first and only FDA-approved non-invasive stool DNA screening test for colorectal cancer(CRC)
  •  Pfizer will co-promote Cologuard with Exact from Q4’18- also share total profits and marketing costs equally- Exact will take care of all manufacturing and laboratory operations for Cologuard
  • Cologuard is a DNA screening test approved by FDA in Aug 2014- to screen adults- ≥50 years are at risk for CRC

/ article | Ref: Exact Sciences | Image:  PRNewswire


Tuba was Senior Editor at PharmaShots. She was curious, creative, and passionate about recent updates and innovations in the life sciences industry. She covered Biopharma, MedTech, and Digital health segments. Tuba also had an experience in digital and social media marketing and ran the campaigns independently. She can be contacted at connect@pharmashots.com.

Share this article on WhatsApp, LinkedIn and Twitter

Join the PharmaShots family of 12000+ subscribers

I accept the Terms and Conditions